MSN Pharmachem Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step β so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Plot No.: 182 to 186, 192-A, 193 to 197 & 212/ A,B,C,D, Phase-II IDA Pashamylaram, Pashamylaram (Village), Patancheru (Mandal), Sangareddy District, Telangana 502307, India (IND)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3006165229 Β· DUNS 677318200
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-04-21
- NAIDrug Quality Assurance2018-05-18
- NAIDrug Quality Assurance2014-06-13
- NAIDrug Quality Assurance2011-08-05
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- aprepitantHeron Therapeutics, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.